HeartWare International, Inc. (NASDAQ: HTWR) announced a series of scientific presentations, highlighting the clinical and commercial use of the HVAD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE